It is already a reality!
Pharmaceutical Roche Diabetes Care has launched a implantable sensor for people with diabetes that measures the blood sugar level continuously for 6 months, 12 times more than any other device available in Europe, without having to change it every 15 days.
The new sensor allows to detect and correct serious hyper situations or hypommias, even during the night, thanks to a sophisticated vibration alert system, and, unlike other sensors, their readings are not affected by the taking of drugs such asParacetamol.
"We are very satisfied to bring this advance to people who live with diabetes. Our goal is to offer a comprehensive management of this disease, improving the quality of life with solutions adapted to the needs of their day to day," said LisaHuse, general director of Roche Diabetes Care Spain.
The new system consists of three interconnected elements: a glucose sensor, an intelligent transmitter and a mobile application.
The sensor is a small capsule, the size of a pill, which is implanted in the upper arm, and the transmitter is placed on the sensor, which is rechargeable and water resistant.
From there the data is sent to an application installed in the 'smartphone' of the user that allows you to see the readings in real time.
One of the characteristics of the system is that the sensor and the transmitter are not physically connected as in the rest of the continuous meters.
The transmitter adheres to the surface of the arm and can be extracted at any time, and, when the transmitter battery is re -placed, the implanted sensor activates and it, in turn, sends the data to the transmitter, which calculates theglucose values and transfers them by 'Bluetooth' to the patient's phone.
In addition, the transmitter has the ability to store registered values and provide vibratory alerts that the patient can notice in his arm when glucose levels are too high or too low.
This new implantable system has been tested in 87 patients from eleven hospitals in Spain for 3 months.